These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30905494)

  • 1. Contralateral prophylactic mastectomy: What should not be forgotten to improve communication between clinicians and patients!
    Franceschini G; Di Leone A; Masetti R
    Patient Educ Couns; 2019 Aug; 102(8):1573-1574. PubMed ID: 30905494
    [No Abstract]   [Full Text] [Related]  

  • 2. B-Sure: a randomized pilot trial of an interactive web-based decision support aid versus usual care in average-risk breast cancer patients considering contralateral prophylactic mastectomy.
    Manne SL; Smith BL; Frederick S; Mitarotondo A; Kashy DA; Kirstein LJ
    Transl Behav Med; 2020 May; 10(2):355-363. PubMed ID: 30608607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decisional conflict among breast cancer patients considering contralateral prophylactic mastectomy.
    Manne S; Smith B; Mitarotondo A; Frederick S; Toppmeyer D; Kirstein L
    Patient Educ Couns; 2019 May; 102(5):902-908. PubMed ID: 30553577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contralateral prophylactic mastectomy: Warnings for a difficult decision to make with caution!
    Franceschini G; Di Leone A; Masetti R
    Am J Surg; 2019 Nov; 218(5):1031-1032. PubMed ID: 30691675
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of anticipated financial burden on patient decision to undergo contralateral prophylactic mastectomy.
    Huang J; Chagpar A
    Surgery; 2018 Oct; 164(4):856-865. PubMed ID: 30093279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contralateral prophylactic mastectomy: A qualitative approach to exploring the decision making process.
    Greener JR; Bass SB; Lepore SJ
    J Psychosoc Oncol; 2018; 36(2):145-158. PubMed ID: 29064771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitating decision-making in women undergoing genetic testing for hereditary breast cancer: BRECONDA randomized controlled trial results.
    Sherman KA; Kilby CJ; Shaw LK; Winch C; Kirk J; Tucker K; Elder E
    Breast; 2017 Dec; 36():79-85. PubMed ID: 29031121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing the Dilemma of Contralateral Prophylactic Mastectomy With Behavioral Science.
    Sacks GD; Morrow M
    J Clin Oncol; 2021 Feb; 39(4):269-272. PubMed ID: 33275488
    [No Abstract]   [Full Text] [Related]  

  • 9. What surgical oncology providers and women with sporadic breast cancer should not forget in the decision-making about contralateral prophylactic mastectomy!
    Franceschini G; Di Leone A; Masetti R
    Transl Behav Med; 2020 May; 10(2):364-365. PubMed ID: 30698813
    [No Abstract]   [Full Text] [Related]  

  • 10. Breast Cancer Genetics and Indications for Prophylactic Mastectomy.
    Krontiras H; Farmer M; Whatley J
    Surg Clin North Am; 2018 Aug; 98(4):677-685. PubMed ID: 30005767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for Guidelines: An Assessment of the American Society of Breast Surgeons Contralateral Prophylactic Mastectomy Consensus Statement.
    Tuttle TM; Barrio AV; Klimberg VS; Giuliano AE; Chavez-MacGregor M; Buum HA; McMasters KM
    Ann Surg Oncol; 2017 Jan; 24(1):1-2. PubMed ID: 27783164
    [No Abstract]   [Full Text] [Related]  

  • 12. Mastectomy for risk reduction or symmetry in women without high risk gene mutation: A review.
    Kenny R; Reed M; Subramanian A
    Int J Surg; 2018 Feb; 50():60-64. PubMed ID: 29288115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redefining Risk and Benefit: Understanding the Decision to Undergo Contralateral Prophylactic Mastectomy.
    Rendle KA; Halley MC; May SG; Frosch DL
    Qual Health Res; 2015 Sep; 25(9):1251-9. PubMed ID: 25371380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and pilot testing of a Decision Aid (DA) for women with early-stage breast cancer considering contralateral prophylactic mastectomy.
    Ager B; Jansen J; Porter D; Phillips KA; Glassey R; ; Butow P
    Breast; 2018 Aug; 40():156-164. PubMed ID: 29857282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why Are There So Many Mastectomies in the United States?
    Mamtani A; Morrow M
    Annu Rev Med; 2017 Jan; 68():229-241. PubMed ID: 27576011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision Making in the Surgical Management of Invasive Breast Cancer-Part 1: Lumpectomy, Mastectomy, and Contralateral Prophylactic Mastectomy.
    Newman LA
    Oncology (Williston Park); 2017 May; 31(5):359-68. PubMed ID: 28512732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?
    Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Costa D; Musiello T; Marven M; Butow P
    Breast; 2017 Feb; 31():233-240. PubMed ID: 27969575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contralateral prophylactic mastectomy in women with breast cancer without a family history or genetic predisposition : Consensus statement from the Austrian Gynecologic Oncology Working Group of the Austrian Society of Obstetrics and Gynecology.
    Bjelic-Radisic V; Singer C; Tamussino K; Kölbl H; Petru E; Volgger B; Polterauer S; Oppelt P; Sevelda P; Bogner G; Marth C;
    Wien Klin Wochenschr; 2019 May; 131(9-10):233-236. PubMed ID: 30887224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.
    Hamilton JG; Genoff MC; Salerno M; Amoroso K; Boyar SR; Sheehan M; Fleischut MH; Siegel B; Arnold AG; Salo-Mullen EE; Hay JL; Offit K; Robson ME
    Breast Cancer Res Treat; 2017 Apr; 162(2):297-306. PubMed ID: 28150129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.
    Rosenberg SM; Sepucha K; Ruddy KJ; Tamimi RM; Gelber S; Meyer ME; Schapira L; Come SE; Borges VF; Golshan M; Winer EP; Partridge AH
    Ann Surg Oncol; 2015 Nov; 22(12):3809-15. PubMed ID: 25930247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.